GAVI

Recent coverage has focused on GAVI's push for systemic reform in global health architecture and its central role in vaccine development efforts, particularly surrounding an emerging Ebola strain. Headlines highlight GAVI's CEO advocacy for restructuring the global health system to prioritize equity and innovation, as well as the organization's collaborative approach to vaccine development. Coverage also reflects renewed U.S. engagement with GAVI following a period of withdrawal, with senior U.S. officials endorsing the organization's mission during a public health crisis.

Summarized from the headlines in the sidebar; see each source for the full story.